Clinical Trials Browser

Phase 3 × Terminated × Endocrine × Clear all

NCT02010957 2025-06-10

FAMIAN

Phase 3 Terminated

Adrenal Gland Neoplasms

NCT02683941 2022-07-06

SPINET

Phase 3 Terminated

77 enrolled 20 charts

Neuroendocrine Tumors in Lung

NCT02419664 2022-03-31

Ga-68-DOTATOC -PET in the Management of Pituitary Tumours

Phase 3 Terminated

Acromegaly, Pituitary Diseases, Pituitary Neoplasms

NCT03602495 2021-12-13

DTC

Phase 3 Terminated

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT03050398 2020-05-28

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

Phase 3 Terminated

8 enrolled 4 charts

BreastEndocrine

Breast Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT00092287 2020-04-30

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Phase 3 Terminated

Malignant Carcinoid Syndrome, Serotonin Syndrome

NCT01843062 2019-08-28

ASTRA

Phase 3 Terminated

233 enrolled 14 charts

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT02465112 2019-02-28

TERAVECT

Phase 3 Terminated

Digestive Neuroendocrine Tumors

NCT00227136 2018-04-13

Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion

Phase 3 Terminated

Carcinoid Tumor, Neuroendocrine Tumors

NCT01755182 2016-05-06

LOTUS

Phase 3 Terminated

Neuroendocrine Tumors

NCT00767338 2013-07-02

VIA

Phase 3 Terminated

3 enrolled 3 charts

Infertility, Multiple Endocrine Neoplasia Type 1